Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Microbial Issues

Intravenous ribavirin for respiratory syncytial viral infections in pediatric hematopoietic SCT recipients

Abstract

Respiratory syncytial virus (RSV) is a potential cause of serious morbidity and even mortality among children undergoing hematopoietic SCT (HSCT). Contrary to the available information regarding the aerosolized formulation of ribavirin, there is a paucity of published studies using i.v. ribavirin in adults, and very few single reports on pediatric patients. Aerosolized drug administration has been limited by potential toxicity and special air-flow requirements. In this regard, i.v. ribavirin could prevent these disadvantages, but its efficacy and safety remain controversial in the pediatric HSCT setting. The present study describes the outcome of six pediatric patients undergoing HSCT with nine episodes of proven RSV. Four episodes corresponded to lower respiratory tract infection (LRTI) and five presented with upper respiratory tract infection (URTI). All LRTI patients showed favorable clinical responses, with 100% survival and no progression to LRTI in the remaining five URTI. No side effects were documented during ribavirin administration. We conclude that ribavirin was well tolerated intravenously, without associated side effects, and was effective in the treatment of RSV in this limited number of pediatric HSCT patients. The role and efficacy of i.v. ribavirin needs to be further clarified by prospective controlled trials in pediatric populations.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Small TN, Casson A, Malak SF, Boulad F, Kiehn TE, Stiles J et al. Respiratory syncytial virus infection following hematopoietic stem cell transplantation. Bone Marrow Transplant 2002; 29: 321–327.

    Article  CAS  Google Scholar 

  2. Raboni SM, Nogueira MB, Tsuchiya LR, Takahashi GA, Pereira LA, Pasquini R et al. Respiratory tract viral infections in bone marrow transplant patients. Transplantation 2003; 76: 142–146.

    Article  Google Scholar 

  3. Nair H, Nokes DJ, Gessner BD, Dherani M, Madhi SA, Singleton RJ et al. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet 2010; 375: 1545–1555.

    Article  Google Scholar 

  4. Langley GF, Anderson LJ . Epidemiology and prevention of respiratory syncytial virus infections among infants and young children. Pediatr Infect Dis J 2011; 30: 510–517.

    Article  Google Scholar 

  5. Riner A, Chan-Tack KM, Murray JS . Intravenous ribavirin--review of the FDA’s Emergency Investigational New Drug Database (1997-2008) and literature review. Postgrad Med 2009; 121: 139–146.

    Article  Google Scholar 

  6. Shah JN, Chemaly RF . Management of RSV infections in adult recipients of hematopoietic stem cell transplantation. Blood 2011; 117: 2755–2763.

    Article  CAS  Google Scholar 

  7. Ochoa Sangrador C, González de Dios J . Consensus conference on acute bronchiolitis (II): epidemiology of acute bronchiolitis. Review of the scientific evidence. An Pediatr (Barc) 2010; 72: 284.e1–284.e23.

    Article  CAS  Google Scholar 

  8. European group for Blood and Marrow Transplantation (EBMT). European conference on infections and leukemia (ECIL), Available from www.ebmt.org/Contents/Resources/Library/ECIL/Pages/ECIL.aspx (accessed on 6 February 2012).

  9. Khanna N, Widmer AF, Decker M, Steffen I, Halter J, Heim D et al. Respiratory syncytial virus infection in patients with hematological diseases: single-center study and review of the literature. Clin Infect Dis 2008; 46: 402–412.

    Article  CAS  Google Scholar 

  10. Ljungman P, Ward KN, Crooks BN, Parker A, Martino R, Shaw PJ et al. Respiratory virus infections after stem cell transplantation: a prospective study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 2001; 28: 479–484.

    Article  CAS  Google Scholar 

  11. Ventre K, Randolph A . Ribavirin for respiratory syncytial virus infection of the lower respiratory tract in infants and young children. Cochrane Database Syst Rev 2010 CD000181.

  12. Fuller HL, Del Mar CB . Immunoglobulin treatment for respiratory syncytial virus infection. Cochrane Database Syst Rev 2010 CD004883.

  13. Anaissie EJ, Mahfouz TH, Aslan T, Pouli A, Desikan R, Fassas A et al. The natural history of respiratory syncytial virus infections in cancer and transplant patients: implications for management. Blood 2004; 103: 1611–1617.

    Article  CAS  Google Scholar 

  14. Sparrelid E, Ljungman P, Ekelöf-Andström E, Aschan J, Ringdén O, Winiarski J et al. Ribavirin therapy in bone marrow transplant recipients with viral respiratory tract infections. Bone Marrow Transplant 1997; 19: 905–908.

    Article  CAS  Google Scholar 

  15. Preston SL, Drusano GL, Glue P, Nash J, Gupta SK, McNamara P . Pharmacokinetics and absolute bioavailability of ribavirin in healthy volunteers as determined by stable-isotope methodology. Antimicrob Agents Chemother 1999; 43: 2451–2456.

    Article  CAS  Google Scholar 

  16. Schleuning M, Buxbaum-Conradi H, Jäger G, Kolb HJ . Intravenous ribavirin for eradication of respiratory syncytial virus (RSV) and adenovirus isolates from the respiratory and/or gastrointestinal tract in recipients of allogeneic hematopoietic stem cell transplants. Hematol J 2004; 5: 135–144.

    Article  CAS  Google Scholar 

  17. Serranti D, Buonsenso D, Ceccarelli M, Gargiullo L, Ranno O, Valentini P . Pediatric hepatitis C infection: to treat or not to treat...what's the best for the child? Eur Rev Med Pharmacol Sci 2011; 15: 1057–1067.

    CAS  PubMed  Google Scholar 

  18. Anak S, Atay D, Unuvar A, Garipardic M, Agaoglu L, Ozturk G et al. Respiratory syncytial virus infection outbreak among pediatric patients with oncologic diseases and/or BMT. Pediatric Pulmonology 2010; 45: 307–311.

    PubMed  Google Scholar 

  19. McCarthy AJ, Kingman HM, Kelly C, Taylor GS, Caul EO, Grier D et al. The outcome of 26 patients with respiratory syncytial virus infection following allogeneic stem cell transplantation. Bone Marrow Transplant 1999; 24: 1315–1322.

    Article  CAS  Google Scholar 

  20. DeVincenzo JP, Hirsch RL, Fuentes RJ, Top FH . Respiratory syncitial virus immune globulin treatment of lower respiratory tract infection in pediatric patients undergoing bone marrow transplantation – a compassionate use experience. Bone Marrow Transplant 2000; 25: 161–165.

    Article  CAS  Google Scholar 

  21. Chávez-Bueno S, Mejías A, Merryman RA, Ahmad N, Jafri HS, Ramil O . Intravenous palivizumab and ribavirin combination for respiratory syncytial virus disease in high-risk pediatric patients. Pediat Infect Dis J 2007; 26: 1089–1093.

    Article  Google Scholar 

  22. The IMpact-RSV Study Group. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics 1998; 102: 531–537.

    Article  Google Scholar 

  23. Nair H, Verma VR, Theodoratou E, Zgaga L, Huda T, Simões EA et al. An evaluation of the emerging interventions against respiratory syncytial virus (RSV)-associated acute lower respiratory infections in children. BMC Public Health 2011; 11 (Suppl 3): S30.

    Article  Google Scholar 

  24. Vettenranta K, Ukkonen P, Saarinen UM . RSV infection complicating the therapy of pediatric malignancies: report of six cases. Med Pediatr Oncol 1996; 26: 261–263.

    Article  CAS  Google Scholar 

  25. Bredius RG, Templeton KE, Scheltinga SA, Claas EC, Kroes AC, Vossen JM . Prospective study of respiratory viral infections in pediatric hemopoietic stem cell transplantation patients. Pediatr Infect Dis J 2004; 23: 518–522.

    Article  Google Scholar 

  26. Avetisyan G, Mattsson J, Sparrelid E, Ljungman P . Respiratory syncytial virus infection in recipients of allogeneic stem-cell transplantation: a retrospective study of the incidence, clinical features, and outcome. Transplantation 2009; 88: 1222–1226.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A Molinos-Quintana.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Molinos-Quintana, A., Pérez-de Soto, C., Gómez-Rosa, M. et al. Intravenous ribavirin for respiratory syncytial viral infections in pediatric hematopoietic SCT recipients. Bone Marrow Transplant 48, 265–268 (2013). https://doi.org/10.1038/bmt.2012.134

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2012.134

Keywords

This article is cited by

Search

Quick links